Objections Force FDA To Withdraw New Rules
The U.S. Food and Drug Administration has withdrawn a set of good manufacturing practice regulations for the pharmaceuticals industry after the public comment period prompted a barrage of objections....To view the full article, register now.
Already a subscriber? Click here to view full article